Smooth muscle migration in vascular development and pathogenesis

Transplant Immunology

Volumn 5, Issue 4, 1997, Pages 255-260

  Schwartz, S M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; BLOOD VESSEL; BLOOD VESSEL INJURY; DEVELOPMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; VASCULAR DISEASE;

EID: 0031470037     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80005-6     Document Type: Article

References (99)

1. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:1995;551-561.
2. Velican C, Velican D. The precursors or coronary atherosclerotic plaques in subjects up to 40 years. Atherosclerosis. 37:1980;33-46.
3. Schwartz SM, de Blois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 77:1995;445-465.
4. Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis. 23:1993;177-182. (Suppl 1).
5. Bendeck MP, Irvin C, Reidy MA. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res. 78:1996;38-43.
6. Clowes AW, Clowes M, Kirkman T, Jackson C, Au Y, Kenagry R. Heparin inhibits the expression of tissue-type plasminogen activator by SMC in injured rat carotid artery. Circ Res. 70:1992;1128-1136.
7. D de Blois, Viswanathan M, Su JE, Clowes AW, Saavedra JM, Schwartz SM. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery: the role of AT1 receptor expression. Arterioscler Thromb Vasc Biol. 16:1996;1130-1137.
8. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to 1 DGF. Science. 253:1991;1129-1132.
9. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter. Arterioscler Thromb. 13:1993;1218-1226.
10. Jackson CL, Reidy MA. Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol. 143:1993;1024-1031.
11. Jackson CL, Reidy MA. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann NY Acad Sci. 667:1992;141-150.
12. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin Invest. 89:1992;507-511.
13. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res. 75:1994;682-691.
14. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat arteries expresses PDGF-B chain mRNA. Circ Res. 76:1995;951-957.
15. Nikkari ST, O'Brien KD, Ferguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 92:1995;1393-1398.
16. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am J Pathol. 140:1992;1017-1023.
17. Prescott M, Webb R, Reidy MA. Angiotensin-converting enzyme inhibitors versus angiotensin II, AT1 receptor antagonist:effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 139:1991;1291-1302.
18. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells - expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 78:1996;427-438.
19. Schwartz SM, Reidy MA, O'Brien ERM. Assessment of factors important in atherosclerosis occlusion and restenosis. Haemostasis. 4:1995;541-551.
20. EJ Su, Lombardi DM, Wiener J, Daemen MJAP, Reidy MA, Schwartz SM. Angiotensin II's proliferative effect on arteries of different sizes can be blocked partially by antibody to basic fibroblast growth factor. Circ Res. 1997;. (in press).
21. Zempo N, Kenagy RD, Au YP, et al. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg. 20:1994;209-217.
22. Powell J, Clozel J, Muller R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation afte vascular injury. Science. 245:1989;186-188.
23. W Osterrieder, RK Muller, Powell JS, Clozet JP, Hefti F., Baumgartner HR. Role of angiotensin II in injury-induced neointimal formation in rats. Hypertension. 18:1991;II60-II64. (Suppl 4).
24. Savani RC, C Wang, Yang B, et al. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin Invest. 95:1995;1158-1168.
25. JE French. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. Int Rev Exp Pathol. 5:1966;253-354.
26. MA Reidy. Neointimal proliferation: The role of basic FGF on vascular smooth mucle proferation. Thromb Haemost. 70:1993;172-176.
27. Bennett MR, Schwartz SM. Antisense therapy for angioplasty restenosis - some critical considerations. Circulation. 92:1995;1981-1993.
28. Campbell GR, Campbell JH. The phenotypes of smooth muscle expressed in human atheroma. Ann NY Acad Sci. 598:1990;153-158.
29. Snow MH. Myogenic cell formation in regenerating rat skeletal muscle injured by mincing. I. A fine structure study. Anat Rec. 88:1977;181-199.
30. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 49:1983;327-333.
31. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 56:1985;139-145.
32. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc. Natl Acad Sci USA. 86:1989;8412-8416.
33. Hanson SR, Powell JS, Dodson T. Effects of angiotensin-converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 18:1991;II70-II76. (suppl II).
34. Wolf YG, Rasmussen LM, Rouslahti E. Antibodies against transforming growth factor-beta 1 suppress intima hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178.
35. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 75:1994;539-545.
36. Bendeck MP, Regenass S, Tom WD. Differential expression of α1 type VIII collagen in injured, platelet-derived growth factor-BB-stimulated rat carotid arteries. Circ Res. 79:1996;524-531.
37. Koyama H, Reidy MA. Reinjury of arterial intimal lesions induces smooth muscle replication which is not controlled by FGF2. Circ Res. 80:1997;408-417.
38. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation. Aterioscler Thromb Vasc Biol. 17:1997;88-193.
39. Ashizawa N, Graf K, Do YS, et al. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest. 98:1996;2218-2227.
40. Weintraub AS, Giachelli CM, Krauss RS, Almeida M, Taubman MB. Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol. 149:1996;259-272.
41. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells. in vitro. Circ. Res. 74:1994;214-224.
42. Gadeau A, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arteriosclerosis Thromb. 13:1993;130-125.
43. Giachelli CM, Bae N, Lombardi DM, Majesky MW, Schwartz SM. Molecular Closing and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 177:1991;867-873.
44. Thayer JM, Giachelli CM, Mirkes PE, Schwartz SM. Expression on osteopontin in the head process late in gastrulation in the rat. J Exp Zool. 272:1995;240-244.
45. 3 in smooth muscle migration to osteopontin in vitro. J Clin Invest. 95:1995;713-724.
46. Matsuno H, Stassen Jm, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 90:1994;2203-2206.
47. 3 integrin with a small peptide antagonist GpenGRDSPCA. J Vasc Surg. 19:1994;125-134.
48. Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six month. EPIC Investigators. Lancet. 343:((8902)):1994;881-886.
49. Mintz GS, Kovach JA, Javier SP, Ditrano CJ, Leon MB. Geometric remodelling is the predominant mechanism of late lumen loss after coronary angioplasty. [Abstract] Circulation. 88:1993;1654. (4 Pt 2).
50. 3 integrin expression in normal and atherosclerotic artery. Circ Res. 77:1995;1129-1135.
51. Skinner MP, Raines EW, Ross R. Dynamic expression of alpha-1-beta-1 and alpha-2-beta-1 integrin receptors by human vascular smooth muscle cells. Alpha-2-beta-1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol. 145:1994;1070-1081.
52. Gotwals PJ, Chi Rosso G, Lindner V, et al. The alpha-1-beta-1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest. 97:1996;2469-2477.
53. Clyman RI, Goetzman BW, Chen YQ, et al. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: an immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus. Paediatric Research. 40:1996;198-208.
54. Svee K, White J, Vaillant P, et al. Acute lung injury fibroblast migration and invation of a fibrin matrix is mediated by CD44. J Clin Invest. 98:1996;1713-1727.
55. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand integration between CD$$ and osteopontin (Eta-1). Science. 271:1996;509-512.
56. Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB. CD44-related chondroitin surface proteoglycan, a cell surface receptor implicated with tumour cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest. 97:1996;2541-2552.
57. Jain M, He Q, Lee WS, et al. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 97:1996;596-603.
58. Boudreau N, Turley E, Rabinovitch M. Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Devel Biol. 143:1991;235-247.
59. Savani RC, Turley EA. The role of hyaluronan and its receptors in restenosis after balloon angioplasty: development of a potential therapy. Int J Tissue React. 17:1995;141-151.
60. Au YP, Dobrowolska G, Morris DR, Clowes AW. Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ Res. 75:1994;15-22.
61. Au YP, Montgomery KF, Clowes AW. Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circ Res. 70:1992;1062-1069.
62. Au YP, Kenagy RD, Clowes AW. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem. 67:1992;3438-3444.
63. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest. 90:1992;2044-2049.
64. Lindner V, Olson NE, Clowes AW, Reidy MA. Heparin inhibits smooth muscle cell proliferation in injured rat arteries by displacing basic fibroblast growth factor. J Clin Invest. 90:1992;2044-2049.
65. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 111:1990;743-755.
66. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metaloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 16:1996;28-33.
67. Noden DM. Embryonic origins and assembly of blood vessels. Rev Resp Dis. 140:1989;1097-1103.
68. LeLievre C, LeDouarin NM. Mesenchymal derivities if the neural crest: analysis of chimeric quail and chick embryos. J Embryol Exp Morphol. 34:1975;125-154.
69. D'Amore Pa. Capillary growth: a two-cell system. Semin Cancer Biol. 3:1992;49-56.
70. Schor AM, Canfield AE, Sutton AB, Archiniegas E, Allen TD. Pericyte differentiation. Clin Orthop. 313:1995;81-91.
71. Majesky MW. An origin for smooth muscle cells from endothelium. Circ Res. 80:1997;601-603.
72. Majesky MW, Topouzis S. Smooth muscle lineage diversity and atherosclerosis. Atherosclerosis. 10:1995;56.
73. Topouzis S, Majesky MW. Smooth muscle lineage diversity in the thick embryo: two types of aortic SMC differ in growth and receptor-mediated transcriptional response to TGF-beta. Dev Biol. 178:1996;430-445.
74. Gadson PFJ, Rossignol C, McCoy J, Rosenquist TH. Expression of elastin, smooth muscle alpha-actin, and c-jun as a function of the embryonic lineage of vascular smooth muscle cells in vitro. Cell Devel Biol Anim. 29A:1993;773-781.
75. Hood LC, Rosenquist TH. Coronary artery development in the chick: origin and deployment of smooth muscle cells, and the effects of neurat crest ablation. Anal Rec. 234:1992;291-300.
76. Cunha GR, Young P, Hamamato S, Guzman R, Nandi S. Developmental response of adult mammary epithelial cells to various fetal and neonatal mesenchymes. Epithelial Cell Biol. 1:1992;105-118.
77. Soriano P. Abnormal kidney development and hematological disorders in PDGF-β receptor mutant mice. Genes Develop. 8:1994;1888-1896.
78. Bostrom H, Willetts K, Pekny M, et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85:1996;863-873.
79. Levéen P, Pekny M, Gebre Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1994;1875-1887.
80. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res. 32:1996;687-698.
81. Murry CE, Gipaya CT, Bartosek T, Benditt EP, Schwartz SM. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol. 151:1997;697-705.
82. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 70:1973;1753-1756.
83. Thomas WA, Lee KT, Kim DN. Cell population kinetics in atherogenesis. Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine. Ann NY Acad Sci. 454:1985;305-315.
84. Velican D, Velican C. Intimal thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis. 23:1976;345-355.
85. Lemire JM, Potter-Perigo S, Hall KL, Weight TN, Schwartz SM. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression. Arterioscler Thromb Vasc Biol. 16:1996;821-829.
86. Stemme S, Rymo L, Hansson GK. Polyclonal origin T lymphocytes in human atherosclerotic plaques. Lab Invest. 65:1991;654-660.
87. Bobryshev YV, RS Lord. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and atheroprone areas of the normal aorta. Arch Histol Cytol. 58:1995;307-322.
88. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation. 50:1990;537-544.
89. de Ruiter MC, Poelmann RE, JC VanMunsteren, et al. Embryonic endothelial cells transdifferentiate into mesenchymal cell expressing smooth muscle actins in vivo and in vitro. Circ Res. 80:1997;444-451.
90. Krug EL, Rezaee M, Isokawa K, et al. Transformation of cardiac endothelium into cushion mesenchyme is dependent on ES/130; Temporal, spatial, and functional studies in the early chick embryo. Cell Mol Biol Res. 41:1995;263-277.
91. Y Sugi, Markwald RR. Early endocardial formation originates from precardiac mesoderm as revealed by QH-antibody staining. Italian Journal of Anatomy and Embrylogy. 100:1995;263-272. (Suppl).
92. Gabbianelli M., Sargiacomo M., Pelosi E., Testa U., G. Isacchi, Peschle C. "Pure' human hematopoietic progenitors: permissive action of basic fibroblast growth factor" Science. 249:1990;1561-1564.
93. Li J, Sensebé L, Hervé P, Charbord P. Nontransformed colony-derived stromal cell lines from normal human marrows. II. Phenotypic characterization and differentiation pathway. Exp Hematol. 23:1995;133-141.
94. Simmons PJ, Torok Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 78:1991;2848-2853.
95. Charbord P, Lerat H, Newton I, et al. The cytoskeleton of stromal cells from human bone marrow cultures resembles that of cultured smooth muscle cells. Exp Hematol. 18:1990;276-282.
96. Wu MH, Shi Q, Wechezak AR, Clowes AW, Gordon Il, Sauvage LR. Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J Vasc Surg. 21:1995;862-867.
97. Slomp J, Van Munsteren JC, Poelmann RE, DeReeder EG, Bogers AJJC, Gittenberger-de Groot AC. Formation of intimal cushions in the ductus arteriosus as a model for vascular intimal thickening. An immunohistochemical study of changes in extracellular matrix components. Atherosclerosis. 93:1992;25-39.
98. DeReeder EG, Poelmann RE, Van Munsteren JC, Patterson DF, Gittenberger-de Groot AC. Ultrastructural and immunohistochemical changes of the extracellular matrix during intimal cushion formation in the ductus arteriosus of the dog. Atherosclerosis. 79:1989;29-40.
99. 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res. 79:1996;821-826.